BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29688306)

  • 21. Large-scale Direct Targeting for Drug Repositioning and Discovery.
    Zheng C; Guo Z; Huang C; Wu Z; Li Y; Chen X; Fu Y; Ru J; Ali Shar P; Wang Y; Wang Y
    Sci Rep; 2015 Jul; 5():11970. PubMed ID: 26155766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LRSSL: predict and interpret drug-disease associations based on data integration using sparse subspace learning.
    Liang X; Zhang P; Yan L; Fu Y; Peng F; Qu L; Shao M; Chen Y; Chen Z
    Bioinformatics; 2017 Apr; 33(8):1187-1196. PubMed ID: 28096083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SigSeeker: a peak-calling ensemble approach for constructing epigenetic signatures.
    Lichtenberg J; Elnitski L; Bodine DM
    Bioinformatics; 2017 Sep; 33(17):2615-2621. PubMed ID: 28449120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Drug-Gene-Disease Associations by Tensor Decomposition for Network-Based Computational Drug Repositioning.
    Kim Y; Cho YR
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
    PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational drug repositioning based on multi-similarities bilinear matrix factorization.
    Yang M; Wu G; Zhao Q; Li Y; Wang J
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomedical data and computational models for drug repositioning: a comprehensive review.
    Luo H; Li M; Yang M; Wu FX; Li Y; Wang J
    Brief Bioinform; 2021 Mar; 22(2):1604-1619. PubMed ID: 32043521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting drug-induced transcriptome responses of a wide range of human cell lines by a novel tensor-train decomposition algorithm.
    Iwata M; Yuan L; Zhao Q; Tabei Y; Berenger F; Sawada R; Akiyoshi S; Hamano M; Yamanishi Y
    Bioinformatics; 2019 Jul; 35(14):i191-i199. PubMed ID: 31510663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
    Wang X; Yan R
    J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel individualized drug repositioning approach for predicting personalized candidate drugs for type 1 diabetes mellitus.
    Zheng H
    Stat Appl Genet Mol Biol; 2019 Jul; 18(5):. PubMed ID: 31287801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.
    Chan J; Wang X; Turner JA; Baldwin NE; Gu J
    Bioinformatics; 2019 Aug; 35(16):2818-2826. PubMed ID: 30624606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BE-DTI': Ensemble framework for drug target interaction prediction using dimensionality reduction and active learning.
    Sharma A; Rani R
    Comput Methods Programs Biomed; 2018 Oct; 165():151-162. PubMed ID: 30337070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational Prediction of Drug-Target Interactions via Ensemble Learning.
    Ezzat A; Wu M; Li X; Kwoh CK
    Methods Mol Biol; 2019; 1903():239-254. PubMed ID: 30547446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PREDICT: a method for inferring novel drug indications with application to personalized medicine.
    Gottlieb A; Stein GY; Ruppin E; Sharan R
    Mol Syst Biol; 2011 Jun; 7():496. PubMed ID: 21654673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.